A Little Below the Belt magazine - Summer 2020

Page 36

The importance of data to improve patient outcomes with bladder cancer

Bladder cancer occurs when abnormal cells in the bladder grow and divide in an uncontrolled manner. It can take different forms. It is the fourth most common cancer in Australian men with the most common symptom of bladder cancer being blood in the urine, which can occur suddenly and is generally not painful. In 2020 an estimated 3098 people in Australia will be diagnosed with bladder cancer. Radical cystectomy (bladder removal) surgery for bladder cancer is associated with significant risk of morbidity and mortality to patients. Currently there is a lack of good quality research carried out specifically in patients who underwent radical cystectomy to identify treatments or interventions that actually improve patient outcome. The ACCEPT study is a secure online collaborative multicentre cystectomy database which acts as a portal for data collection. The data obtained will allow healthcare professionals to analyse the type of interventions currently used by participating urologists and the associated outcome and complications. Subsequently, this information will be used to formulate intervention and control arms for a future randomised controlled trial. The study is led by ANZUP member Professor Dickon Hayne based at Fiona Stanley Hospital in Perth, Western Australia. To date there are 78 patients participating in the study with six other member sites and their patients in Queensland, Victoria and NSW preparing to join the study over the coming months. This is the first study of its type for bladder cancer.

36 A LITTLE BELOW THE BELT

At ANZUP’s recent Annual Scientific Meeting, Prof Hayne presented an update on the progression of the ACCEPT study: • F irst reported data from the database is being analysed; • T he range of data includes large contemporary and unselected Australian cases; • R esults compare favourably to national and international literature particularly in relation to major complications and mortality; • S upports evidence based principles of high volume surgeons and centres and adoption of best practice to improve cystectomy outcomes; • Widespread participation is encouraged to help improve patient outcomes across Australia, New Zealand and globally.

“We are delighted to have data from the ACCEPT database to analyse. Working into the future we hope to galvanise additional multicentres to make this project a truly effective tool for cancer.” Professor Dickon Hayne. The ACCEPT study has been funded by ANZUP’s Below the Belt Research Fund and more recently support has been received from the McCusker Foundation. ANZUP is extremely grateful to the McCusker Foundation for their support.


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Below the Belt #YourWay

14min
pages 64-75

Good2Give

1min
page 62

ANZUP Trials - Kidney

3min
pages 50-51

ANZUP Trials - Testicular

4min
pages 44-45

ANZUP trials - bladder

2min
pages 37-38

Fiona Stanley Hospital urological surgeon puts songwriting talent to the test for Below the Belt campaign

2min
page 34

Spotlight on bladder and urothelian cancer

1min
page 32

ANZUP Trials - Prostate

1min
page 28

Contents

1min
page 4

How can you get involved?

3min
page 61

2020 Below the Belt Research Fund Recipients

6min
pages 59-60

Trials in follow up

11min
pages 56-58

What are the barriers and facilitators to interdisciplinary models of person-centred supportive care in the context of penile cancer? A mixed methods study

4min
pages 54-55

Spotlight on penile cancer

3min
pages 52-53

A pilot study for Kidney Cancer

4min
pages 49-51

Kidney Cancer and Immunotherapy

2min
page 48

Spotlight on kidney cancer

4min
pages 46-47

Testicular Cancer Research Highlights

9min
pages 42-45

Spotlight on testicular cancer

4min
pages 40-41

The role of the Prostate Cancer Subcommittee

11min
pages 26-31

The importance of data to improve patient outcomes with bladder cancer

4min
pages 36-38

Where are we in demonstrating economic value in prostate cancer trials

3min
page 25

Recruitment nearing completion for world first trial for bladder cancer

1min
page 39

Worldwide prostate cancer trial continues to strongly recruit

2min
page 24

Advanced Prostate Cancer Consensus Conference (APCCC): Asia-Pacific (APAC) Satellite Symposium

2min
page 23

ANZUP’s ENZAMET trial is awarded all three of ACTA’s Trial of the Year Awards

4min
pages 21-22

Finding a clinical pathway during a pandemic

4min
pages 14-16

Spotlight on prostate cancer

4min
pages 19-20

Friends of ANZUP

0
page 13

Consumer Advisory Panel (CAP) Update

6min
pages 9-10

Kev’s Crew

3min
pages 11-12

CEO Update

6min
pages 7-8

Meet Associate Professor Arun Azad

3min
pages 17-18

Message from the Chair, Professor Ian Davis

9min
pages 5-6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.